Skip to main content
Log in

The IGF system in a case of Costello syndrome

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Costello syndrome is characterized by facial dysmorphia, hyperpigmented skin, palmar and plantar hyperkeratosis, curly hair, perioral and nasal papillomata (more rarely localized anally and on vocal cords), short stature, mental retardation and sociable personality. Although growth retardation is typical of Costello syndrome, its cause is not defined. We report on a 10-yr-old Caucasian girl affected by Costello syndrome with fasting hypoglycemia and short stature, associated low circulating levels of acid-labile subunit (ALS), relatively low levels of IGF-I and IGFBP-3, and normal IGF-II, mostly circulating in a binary complex with IGFBP-2 and -6 instead of in a 150 kDa ternary complex. The reduced ALS concentration and the consequent impaired formation of the circulating 150 kDa ternary complex can induce an accelerated clearance rate of IGF peptides and of IGFBP-3, contributing to the decreased IGF-I growth promoting activity in our patient. Moreover, the presence of IGF-II in the binary complex, which has been postulated to increase the insulin-like effects of these peptides, can explain, at least in part, the patient’s asymptomatic fasting hypoglycemia. (J. Endocrinol. Invest. 29: 261–264, 2006)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Costello JM. A new syndrome: Mental subnormality and nasal papillomata. Aust Paediatr J 1977, 13: 114–8.

    PubMed  CAS  Google Scholar 

  2. Der Kalousian V.M., Moroz B., McIntosh N., Watters K., Blaichman S. Costello syndrome. Am J Med Genet 1991, 4: 69–73.

    Google Scholar 

  3. Zampino G, Mostroiacovo P, Ricci R, et al. Costello syndrome: further clinical delineation, natural history, genetic definition, and nosology. Am J Med Genet 1993, 47: 176–83.

    Article  PubMed  CAS  Google Scholar 

  4. Borochowitz Z, Pavone L, Mazor G, Rizzo R, Dar H. New multiple congenital anomalies: mental retardation syndrome (MCA/MR) with facio-cutaneous-skeletal involvement. Am J Med Genet 1992, 43: 678–85.

    Article  PubMed  CAS  Google Scholar 

  5. Lurie IW. Genetics of the Costello syndrome. Am J Med Genet 1994, 52: 358–9.

    Article  PubMed  CAS  Google Scholar 

  6. Johnson JP, Golabi M, Norton ME, et al. Costello syndrome: Phenotype, natural history, differential diagnosis, and possible cause. J Pediatr 1998, 133: 441–8.

    Article  PubMed  CAS  Google Scholar 

  7. Okamoto N, Chiyo H, Imai K, Otani K, Futagi Y. A Japanese patient with the Costello syndrome. Hum Genet 1994, 93: 605–6.

    Article  PubMed  CAS  Google Scholar 

  8. Legault L, Gagnon C, Lapointe N. Growth hormone deficiency in Costello syndrome: A possible explanation for the short stature. J Pediatr 2001, 138: 151–2.

    Article  PubMed  CAS  Google Scholar 

  9. Di Rocco M, Gatti R, Gandullia P, Barabino A, Picco P, Borrone C. Report on two patients with Costello syndrome and sialuria. Am J Med Genet 1993, 47: 1135–40.

    Article  PubMed  Google Scholar 

  10. Baxter RC, Martin JL, Beniac VA. High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. J Biol Chem 1989, 264: 11843–8.

    PubMed  CAS  Google Scholar 

  11. Barreca A, Ponzani P, Arvigo M, Giordano G, Minuto F. Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J Clin Endocrinol Metab 1995, 80: 1318–24.

    PubMed  CAS  Google Scholar 

  12. Zapf J, Schmid C, Froesch ER. Biological and immunological properties of insulin-like growth factors I and II. J Clin Endocrinol Metab 1984, 13: 3–30.

    Article  CAS  Google Scholar 

  13. Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A. Diagnostic value of the acid-labile subunit (ALS) in acromegaly. Evaluation in comparison with insulin-like growth factor (IGF)-I, and IGF binding proteins (IGFBP-1, -2, -and -3). J Clin Endocrinol Metab 2001, 86: 1091–8.

    PubMed  CAS  Google Scholar 

  14. Jones J, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16: 3–34.

    PubMed  CAS  Google Scholar 

  15. Zapf J, Hauri C, Futo E, et al. Intravenously injected insulin-like growth factor (IGF) I/GF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 1995, 95: 179–86.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  16. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark RG. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 1996, 137: 1913–20.

    PubMed  CAS  Google Scholar 

  17. Murphy LJ, Molnar P, Lu X, Huang H Expression of human insulin-like growth factor binding protein-3 in transgenic mice]. J Mol Endocrinol 1995, 15: 293–303

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Boschetti MD.

Additional information

This author died on September 28, 2004.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barreca, A., Cotellessa, M., Boschetti, M. et al. The IGF system in a case of Costello syndrome. J Endocrinol Invest 29, 261–264 (2006). https://doi.org/10.1007/BF03345551

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345551

Key Words

Navigation